News

Pharmabiz2h
Pasithea completes enrollment and initial dosing of first Cohort from its phase 1/1b trial of PAS-004 in adult NF1 patients
Pasithea completes enrollment and initial dosing of first Cohort from its phase 1/1b trial of PAS-004 in adult NF1 patients: Miami Saturday, August 2, 2025, 18:00 Hrs [IST] Pasith ...
Pharmabiz4h
BioDuro & Atombeat enter strategic partnership to launch an AI-powered platform for accelerated peptide drug discovery
BioDuro & Atombeat enter strategic partnership to launch an AI-powered platform for accelerated peptide drug discovery: Irvine, California Saturday, August 2, 2025, 16:00 Hrs [IST ...
Pharmabiz3h
US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis
US FDA approves SetPoint Medical’s novel neuroimmune modulation device, SetPoint System for rheumatoid arthritis: Valencia, California Saturday, August 2, 2025, 17:00 Hrs [IST] ...
Pharmabiz4h
Marengo Asia Hospitals inks strategic clinical partnership with Metis – The Medicity Hospital, Varanasi
Marengo Asia Hospitals inks strategic clinical partnership with Metis – The Medicity Hospital, Varanasi: Our Bureau, Mumbai Saturday, August 2, 2025, 15:40 Hrs [IST] Marengo Asi ...
Pharmabiz5h
US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke
US FDA grants fast track designation to Revalesio’s lead investigational therapy, RNS60 to treat acute ischemic stroke: Tacoma, Washington Saturday, August 2, 2025, 15:00 Hrs [I ...
Pharmabiz7h
Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care
Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...
Pharmabiz6h
Plus Therapeutics’ subsidiary, CNSide to launch CNSide cerebrospinal fluid assay platform in US
Plus Therapeutics’ subsidiary, CNSide to launch CNSide cerebrospinal fluid assay platform in US: Houston Saturday, August 2, 2025, 14:00 Hrs [IST] Plus Therapeutics, Inc., a cli ...
Pharmabiz8h
Medicenna strengthens IP portfolio with five patents granted for its IL-2 and IL-4 Superkines
US Patent No. 12,202,873 – Superagonists, Partial Agonists and Antagonists of IL-2. Also granted in Switzerland, China, Germany, France, United Kingdom, India, and Japan and allowed in Canada with ...
Pharmabiz10h
UKHSA study shows RSV vaccine highly effective in preventing hospitalisation
UKHSA study shows RSV vaccine highly effective in preventing hospitalisation: United Kingdom Saturday, August 2, 2025, 10:00 Hrs [IST] A new UK Health Security Agency study - Effe ...
Pharmabiz9h
US FDA requires major changes to opioid pain medication labelling to emphasize risks
US FDA requires major changes to opioid pain medication labelling to emphasize risks: Maryland Saturday, August 2, 2025, 11:00 Hrs [IST] The US Food and Drug Administration (FDA) ...
Pharmabiz12h
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [I ...
Pharmabiz12h
Health ministry amends Cosmetics Rules, 2020 to add specifics for cancellation & suspension of licence
Health ministry amends Cosmetics Rules, 2020 to add specifics for cancellation & suspension of licence: Gireesh Babu, New Delhi Saturday, August 2, 2025, 08:00 Hrs [IST] The Union ...